Charles River utilizes a truly integrated approach to small molecule drug discovery, uniting all of the key disciplines required to achieve a program's goals in a single project team. As an experienced drug discovery organization, we are able to tailor project resources to meet the client's specific needs, integrating chemistry, physical sciences, CADD, biology, structural biology, ADMET/PK and disease models as required.

New Strategy to Reduce Hearing Loss Associated with Usher Syndrome

The approach highlighted in this article can be applied to identify drugs for other protein-destabilizing monogenic disorders like USH3. Read article »

I need to...